MARCKSL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 9.18487508272392E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.13282733088727E-12 |
Normal-vs-Stage2 |
6.018100E-04 |
Normal-vs-Stage3 |
1.34919999950078E-07 |
Normal-vs-Stage4 |
3.65579999994647E-06 |
Stage1-vs-Stage2 |
3.297800E-01 |
Stage1-vs-Stage3 |
3.967800E-01 |
Stage1-vs-Stage4 |
9.482200E-01 |
Stage2-vs-Stage3 |
7.455400E-01 |
Stage2-vs-Stage4 |
4.396800E-01 |
Stage3-vs-Stage4 |
5.261000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.28426175144614E-12 |
Normal-vs-AfricanAmerican |
5.60019999999994E-05 |
Normal-vs-Asian |
2.532800E-01 |
Caucasian-vs-AfricanAmerican |
4.730400E-01 |
Caucasian-vs-Asian |
2.640200E-01 |
AfricanAmerican-vs-Asian |
5.062400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.27630153509995E-11 |
Normal-vs-Female |
6.25099971784948E-11 |
Male-vs-Female |
2.651400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.78630000000313E-05 |
Normal-vs-Age(41-60Yrs) |
1.22699628235523E-11 |
Normal-vs-Age(61-80Yrs) |
5.47910050663347E-10 |
Normal-vs-Age(81-100Yrs) |
8.921800E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.367200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.072400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.161900E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.388200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.650820E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.882000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.467600E-02 |
Normal-vs-Grade 2 |
3.34732241924485E-13 |
Normal-vs-Grade 3 |
9.61339999827615E-08 |
Normal-vs-Grade 4 |
1.37349999995706E-06 |
Grade 1-vs-Grade 2 |
4.014200E-01 |
Grade 1-vs-Grade 3 |
2.058600E-01 |
Grade 1-vs-Grade 4 |
3.504200E-01 |
Grade 2-vs-Grade 3 |
2.916000E-02 |
Grade 2-vs-Grade 4 |
6.829400E-01 |
Grade 3-vs-Grade 4 |
2.595400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.80150047394079E-10 |
Normal-vs-ccB subtype |
5.18389997594682E-10 |
ccA subtype-vs-ccB subtype |
3.875200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.40560008077273E-10 |
Normal-vs-N1 |
1.224030E-01 |
N0-vs-N1 |
1.348250E-02 |
|
|